Si Tuen Lee-Hoeflich

Si Tuen Lee-Hoeflich

Company: Scholar Rock

Job title: Director, Translational Sciences


Development of a Comprehensive Biomarker Strategy to Support DRAGON, a Phase 1 Clinical Trial of SRK-181, the Latent TGFβ1 Inhibitor 11:00 am

• Preclinical data demonstrate that combining SRK-181 with a PD-1 inhibitor modifies the immune profile within the tumor immune microenvironment • A comprehensive biomarker strategy is being developed to support the ongoing DRAGON trial and further explore the mechanism of action of SRK-181 • Ongoing evaluation of immune biomarkers and establishment of image analysis-based methods…Read more

day: Track B - Day 2 AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.